rofecoxib has been researched along with Neuroectodermal Tumors, Primitive in 1 studies
Neuroectodermal Tumors, Primitive: A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)
Excerpt | Relevance | Reference |
---|---|---|
"Celecoxib was more potent than rofecoxib in suppressing cell growth." | 1.31 | Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib. ( Gumired, K; Patti, R; Phillips, PC; Reddanna, P; Reddy, CD; Sutton, LN, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Patti, R | 1 |
Gumired, K | 1 |
Reddanna, P | 1 |
Sutton, LN | 1 |
Phillips, PC | 1 |
Reddy, CD | 1 |
1 other study available for rofecoxib and Neuroectodermal Tumors, Primitive
Article | Year |
---|---|
Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Brain; Brain Neoplasms; Caspase 3; Caspases; Ce | 2002 |